PedAM
Pediatric Disease Annotations & Medicines
| Disease | lung cancer |
| Phenotype | C0024299|lymphoma |
| Sentences | 14 |
| PubMedID- 23618014 | Compared to the normal population, second primary malignancy (in particular leukaemia and lung cancer) in patients with malignant lymphoma during their long-term survival has been seen occasionally. |
| PubMedID- 25257756 | Cell block samples from malignant pleural effusion might be valid alternative samples for anaplastic lymphoma kinase detection in patients with advanced non-small-cell lung cancer. |
| PubMedID- 21490772 | This review will focus on current knowledge of the beneficial effects of hdl-cholesterol as it relates to cardiovascular diseases, breast and lung cancers, non-hodgkin's lymphoma, as well as its neuroprotective potential in reducing the risk of alzheimer's disease and dementia. |
| PubMedID- 26253541 | Representatives of hematoxylin–eosin (h&e) staining and fluorescence in situ hybridization (fish) in non–small cell lung cancer (nsclc) lesions with anaplastic lymphoma kinase (alk) rearrangement. |
| PubMedID- 23524472 | Primary lung cancer complicated by malignant lymphoma in two cases of epstein-barr virus infection. |
| PubMedID- 25170012 | Fda approval summary: crizotinib for the treatment of metastatic non-small cell lung cancer with anaplastic lymphoma kinase rearrangements. |
| PubMedID- 23560836 | Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment. |
| PubMedID- 20609777 | We matched lymphoma patients with lung cancer patients who had no lymphoma based on age, gender, surgery type, comorbidities, stage, and histology. |
| PubMedID- 23618692 | Aims: in lung cancer with anaplastic lymphoma kinase (alk) gene rearrangement, accurate diagnosis is essential to identify patients who can be treated with a specific kinase inhibitor. |
| PubMedID- 26091466 | lymphoma accounted for 0.24% of all lung cancers. |
| PubMedID- 24885608 | Background: the discovery of the fusion gene echinodermmicro tubule associated proteinlike 4-anaplastic lymphoma kinase, eml4-alk, in patients with non-small-cell lung cancer has led to the remarkable development of anaplastic lymphoma kinase inhibitors, such as crizotinib. |
| PubMedID- 22465695 | Fluorescence in situ hybridization (fish) is currently used to detect non-small cell lung cancer (nsclc) patients with anaplastic lymphoma kinase (alk) gene rearrangement, who are candidates for alk inhibitor therapy. |
| PubMedID- 25624888 | A case of primary lung cancer complicated by lymphoma was described by ohno et al (9). |
| PubMedID- 25682546 | Background: there have been conflicting findings regarding the efficacy of pemetrexed for lung cancer with anaplastic lymphoma kinase (alk) rearrangement. |
Page: 1